AstraZeneca COVID vaccine 70% effective vs. B117 variant

AstraZeneca COVID vaccine 70% effective vs B117 variant – CIDRAP

Original study: Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial – The Lancet

Commentary on Twitter (thread – Click for more)

ASYMPTOMATIC & SYMPTOMATIC Efficacy of Oxford-AstraZeneca #COVID19 vaccine versus #B117 & non-B117 variants via 200k swabs in ~8500:?

Symptomatic #B117➡️ 70%

Asymptomatic #B117➡️ 29%

Other variants symptomatic➡️ 81.5%

Other variants asymptomatic➡️ 70%https://t.co/qSWYlHKP0g pic.twitter.com/gS7P9MCpyz

— Eric Feigl-Ding (@DrEricDing) March 31, 2021